Financials Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 20:00:32 14/07/2026 BST			5-day change	1st Jan Change
475.82 ^USD	-0.92%		-8.93%	+4.91%

07-13	American Academy of Orthopaedic Surgeons Launches New Pain Management Resource Center in Partnership with Curonix LLC Pacira Biosciences, Inc., Vertex Pharmaceuticals, and Viatris	CI
07-13	UBS Adjusts Vertex Pharmaceuticals Price Target to $585 From $545, Maintains Buy Rating	MT

Projected Income Statement: Vertex Pharmaceuticals Incorporated

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,059	14,323	15,942
Change	-	17.91%	10.51%	11.66%	8.9%	8.81%	9.68%	11.31%
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,789	6,648	7,645
Change	-	10.55%	-7.8%	-80.18%	506.21%	5.78%	14.84%	14.99%
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,537	6,257	7,318
Change	-	10.34%	-8.73%	-84.1%	656.63%	5.2%	13.01%	16.95%
Interest Paid ¹	-61.5	-54.8	-44.1	-30.6	-13.3	-16.04	-20.97	-21.41
Earnings before Tax (EBT) ¹	2,730	4,232	4,380	248.5	4,643	5,460	6,290	7,602
Change	-	55.01%	3.48%	-94.33%	1,768.49%	17.58%	15.21%	20.86%
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,506	5,057	5,973
Change	-	41.84%	8.96%	-114.8%	838.09%	14%	12.22%	18.12%
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales ¹	1,793	1,984	2,073	2,098	2,196	2,334	2,303	2,375	2,493	2,484	2,518	2,691	2,646	2,772	2,912	2,770	2,965	3,076	3,190	2,987	3,217	3,356	3,495	3,267	3,448	3,694	3,751
Change	-	10.64%	4.46%	1.2%	4.71%	6.29%	-1.35%	3.13%	4.99%	-0.39%	1.38%	6.87%	-1.67%	4.77%	5.05%	-4.87%	7.02%	3.77%	3.69%	-6.37%	7.71%	4.3%	4.14%	-6.51%	5.54%	7.13%	1.53%
EBITDA ¹	-	-	-	-	-	1,326	1,189	941.1	-	1,215	1,210	1,390	-3,092	1,360	1,245	1,231	1,377	1,439	1,426	1,366	1,445	1,490	1,556	1,512	1,537	1,709	1,885
Change	-	-	-	-	-	-	-10.36%	-20.83%	-	-	-0.4%	14.83%	-322.49%	143.99%	-8.49%	-1.08%	11.81%	4.5%	-0.9%	-4.19%	5.8%	3.05%	4.46%	-2.83%	1.65%	11.19%	10.3%
EBIT ¹	1,029	1,188	1,124	1,166	1,187	1,289	1,150	902.3	1,148	1,173	1,151	1,336	-3,146	1,307	1,198	1,183	1,325	1,385	1,370	1,310	1,373	1,411	1,464	1,464	1,489	1,661	1,837
Change	-	15.42%	-5.41%	3.78%	1.76%	8.63%	-10.79%	-21.56%	27.22%	2.2%	-1.86%	16.07%	-335.43%	141.55%	-8.32%	-1.28%	12.01%	4.51%	-1.05%	-4.37%	4.76%	2.8%	3.72%	0.03%	1.71%	11.55%	10.6%
Charge d'intérêts ¹	-15.48	-15.26	-15.1	-14.9	-14.6	-13.7	-11.6	-11.4	-11.2	-10.9	-10.6	-10.4	-9.9	-7.5	-2.8	-3	-3.7	-3.3	-3.3	-	-5.475	-5.432	-5.743	-3	-3	-3	-3
Earnings before Tax (EBT) ¹	-44.26	1,083	870.9	954.8	1,024	1,176	1,077	891.5	1,162	1,179	1,148	1,279	-3,391	1,224	1,136	730.4	1,283	1,299	1,331	1,253	1,357	1,412	1,454	1,409	1,520	1,575	1,640
Change	-	2,546.6%	-19.57%	9.63%	7.29%	14.84%	-8.47%	-17.21%	30.29%	1.52%	-2.68%	11.46%	-365.12%	136.1%	-7.16%	-35.73%	75.66%	1.23%	2.48%	-5.87%	8.27%	4.08%	3%	-3.11%	7.84%	3.63%	4.17%
Net income ¹	66.92	851.9	770.1	762.1	810.5	930.5	818.9	699.8	915.7	1,035	968.8	1,100	-3,594	1,045	913	646.3	1,033	1,083	1,191	1,031	1,121	1,169	1,201	1,071	1,099	1,262	1,453
Change	-	1,172.98%	-9.61%	-1.04%	6.35%	14.81%	-11.99%	-14.54%	30.85%	13.06%	-6.42%	13.5%	-426.81%	129.09%	-12.67%	-29.21%	59.82%	4.84%	9.99%	-13.41%	8.72%	4.29%	2.7%	-10.83%	2.61%	14.83%	15.13%
Announcement Date	29/07/21	02/11/21	26/01/22	05/05/22	04/08/22	27/10/22	07/02/23	01/05/23	01/08/23	06/11/23	05/02/24	06/05/24	01/08/24	04/11/24	10/02/25	05/05/25	04/08/25	03/11/25	12/02/26	04/05/26	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Vertex Pharmaceuticals Incorporated

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	-7,525	-10,779	-11,218	-6,116	-6,608	-13,743	-18,686	-23,823
Change	-	-43.24%	-4.07%	45.48%	-8.04%	-107.97%	-35.97%	-27.49%
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Vertex Pharmaceuticals Incorporated

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	235	204.7	200.4	297.7	437.6	376.2	383.5	431.9
Change	-	-12.89%	-2.1%	48.55%	46.99%	-14.02%	1.93%	12.62%
Free Cash Flow (FCF) ¹	2,408	3,925	3,337	-790.3	3,194	4,877	5,037	5,468
Change	-	62.97%	-14.99%	-123.68%	504.13%	52.69%	3.28%	8.56%
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Vertex Pharmaceuticals Incorporated

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	59.01%	55.33%	46.16%	8.19%	45.6%	44.36%	46.45%	47.94%
EBIT Margin (%)	57.35%	53.67%	44.33%	6.31%	43.85%	42.41%	43.82%	45.97%
EBT Margin (%)	36.05%	47.39%	44.38%	2.25%	38.69%	41.89%	44.21%	48.36%
Net margin (%)	30.92%	37.2%	36.68%	-4.86%	32.94%	34.6%	35.39%	37.64%
FCF margin (%)	31.8%	43.95%	33.81%	-7.17%	26.61%	37.37%	35.19%	34.29%
FCF / Net Income (%)	102.84%	118.16%	92.19%	147.55%	80.79%	107.99%	99.45%	91.11%
Profitability
ROA	18.84%	21.04%	17.71%	0.49%	16.41%	15.28%	15.12%	15.35%
ROE	36.03%	32.11%	22.99%	0.65%	27.07%	22.76%	21.06%	20.44%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	3.1%	2.29%	2.03%	2.7%	3.65%	2.88%	2.68%	2.71%
CAPEX / EBITDA (%)	5.26%	4.14%	4.4%	32.98%	8%	6.5%	5.77%	5.65%
CAPEX / FCF (%)	9.76%	5.22%	6.01%	-37.67%	13.7%	7.72%	7.61%	7.9%
Items per share
Cash flow per share ¹	10.17	15.94	13.58	-1.91	14.08	26.26	23.55	-
Change	-	56.71%	-14.81%	-114.07%	836.92%	86.56%	-10.3%	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	39.69	54.13	68.22	62.9	73.49	87.32	105.4	125.3
Change	-	36.4%	26.03%	-7.81%	16.84%	18.82%	20.67%	18.89%
EPS ¹	9.01	12.82	13.89	-2.08	15.32	17.55	19.57	23.15
Change	-	42.29%	8.35%	-114.97%	836.54%	14.59%	11.47%	18.31%
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,805	253,805	253,805
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-